Filtered library · Theme
m-and-a-special-situations theme · 86 dossiers
Dossiers in the m-and-a-special-situations theme cluster — 86 names moving on shared catalysts.
All dossiersMRCY
Mercury Systems Inc
Defense-electronics turnaround re-rating inside an accelerating modernization tape: Q3 FY26 (2026-05-06) printed record bookings $348M (+73.7% YoY), 1.48 book-to-bill, record ~$1.6B backlog and +46% EBITDA, with FCF guided positive. But…
SIMO
Silicon Motion Technology Corporation
NAND-controller toll-booth on the steepest flash shortage in ~15 years: TrendForce H1 2026 contract +>100% cumulative, H2 still rising with no capacity adds. Q1 record +105% YoY, sell-side chasing to $400/$450. Fundamental leg…
XPO
XPO, Inc.
Freight-cycle upturn is the accelerating narrative: LTL volume and contract pricing re-accelerating after a multi-year trucking recession, with SAIA May tonnage +8.4% confirming the cluster. XPO layers operating-ratio self-help (Q1 LTL OR…
IRDM
Iridium Communications Inc
Narrative-momentum thesis is closed: Rocket Lab agreed 2026-06-29 to acquire Iridium for ~$54/share ($27 cash + a calculated ratio of RKLB stock), EV ~$8B. IRDM now trades as merger-arb spread to ~$54 plus embedded RKLB beta not on NTN…
MTUM
May 2026 reconstitution rotated MTUM hard into the AI-memory/semiconductor complex (MU 7.2%, INTC, AMD, AVGO, LRCX, AMAT ~30%+ combined); the factor now trades as a leveraged AI-hardware proxy, +30% YTD and pressed against its $345.59…
SPCX
SpaceX (Space Exploration Technologies Corp.)
Nasdaq-100 inclusion flow catalyst fired and faded into a sell-the-news; SPCX is now an unbased $1.77T post-IPO decliner (a post-IPO buyer down ~23%) in the Figma/Circle retreat cohort, with lock-ups ahead and China closing the…
PURR
Hyperliquid Strategies Inc
Hyperliquid proxy has decoupled from a broken crypto tape (BTC sub-$60k, -50% from ATH) and is squeezing on idiosyncratic flow: Russell 2000/3000 reconstitution (effective ~6/29), a small-float gamma-squeeze setup, and HYPE-token relative…
WEST
Westrock Coffee Company
Conway extract/RTD platform inflecting capex to cash: Q1 (5/07) beat revenue with record adjusted EBITDA, FCF-positive-H2 guide reaffirmed, and a 6/30 debt-maturity extension cleared the near-term refi wall. Stock re-rated ~the published…
MRX
Marex Group plc
Roll-up compounder broke out to a new all-time high ($64.23 on 2026-06-26), clearing the $57.43 consensus PT and the prior $58.62 high price now leads every published target. Record Q1 (+48% rev), a second $500M raise (hybrid notes closed…
DLTR
Dollar Tree Inc.
Single-banner discount turnaround still working post-Q1 beat-and-raise, now with a capital-return leg: $2.5B buyback reauthorized (Jul 2, 2026) plus a $500M block repurchased at activist Mantle Ridge's Jun-25 exit price. Story is maturing…
ILMN
Illumina, Inc.
Legacy genomics monopoly in recognition-phase momentum on a clinical-sequencing inflection; sell-side just clustered at $200 (Guggenheim 06-29, Piper 07-01, Evercore 07-06) and 07-09 options whale alerts confirm positioning into the…
MGNI
Magnite, Inc.
Agentic-ad-infra narrative kept adding legs post-Magnite Orchestration (2026-06-11) Viasat, then a Walmart Connect commerce-media deal carrying MGNI from ~$17.89 to the low-$20s. CTV is 51% of net revenue growing 30%, but clustered insider…
PRM
Perimeter Solutions, Inc.
Monopoly wildfire-retardant (PHOS-CHEK) breaking out to new highs as the 2026 fire season runs 195% of the 10-yr average (2.93M acres by June 25). Q1 +74% rev / +128% adj EBITDA confirmed the re-rate and CJS just initiated at a $48 Street…
TRIP
TripAdvisor, Inc.
Activist breakup/sale special situation past its board-control catalyst: Starboard seated its 4th designee at the June 29 annual meeting and sale talk is intensifying, with the $700M TheFork-to-Amex cash sale proving the board will…
VAC
Marriott Vacations Worldwide Corporation
New-management turnaround re-rating still accelerating: VAC punched through Goldman's $100 target to fresh 52-week highs (~$102–106), and Deutsche Bank's June 30 hike to $119 (Buy) reset the ceiling above the tape. But it's extended near…
WLFC
Willis Lease Finance Corporation
Aircraft engine-leasing supercycle spare-engine shortage plus MRO backlog holding lease rates >20% above 2019 drove WLFC's record Q1 (rev +23% to $194.3M, EPS $4.03 vs $3.02 est). Fundamentals still accelerating but the theme is maturing…
ABX
Abacus Global Management, Inc.
Life-settlements franchise attached itself to the RWA-tokenization narrative on 2026-07-07 (100+ policies on-chain, targeting the $224B secondary market by year-end); Q1 beat and raised FY adj-EPS guide to $1.00–1.05. But price rejected…
ALHC
Alignment Healthcare, Inc.
Profitable-MA-disruptor narrative broke on 2026-07-08: a whistleblower suit from a former Chief Transformation Officer alleges the +88% adjusted-EBITDA inflection was manufactured by reclassifying opex as capex across FY2024-25. Shares…
ALOT
AstroNova, Inc.
AstroNova is a closed narrative: Arcline's $29.00 all-cash take-private (announced 2026-06-17, ~$272M, Q3-2026 close) hard-caps the stock. The 200%+ pop was a one-time buyout gap, not an accelerating story what remains is a thin merger-arb…
ANAB
AnaptysBio, Inc.
Pure-play Jemperli/imsidolimab royalty stub since the April spin-off; the entire equity now hinges on the 2026-07-14–17 Delaware Chancery trial on royalty reversion and rate preservation now 1–3 trading days out. A binary legal verdict,…
ANRO
Alto Neuroscience Inc.
Precision-psychiatry re-rate that has already run ~10x off a $2.50 low to near its $28.44 high; funded through 2029 on the March $120M PIPE, but every binary readout (ALTO-300, ALTO-100, ALTO-207 in TRD) sits in 2027 the tape near highs is…
AUGO
Aura Minerals Inc.
Gold/copper producer basing $53–$76 — below its broken ~$72 shelf after a ~45% drop from the $110 high. Q2 production slipped 8% QoQ (first sequential decline after a record Q1) as gold stalls in the low-$4,000s and sell-side trims targets…
AVNS
Avanos Medical, Inc.
All-cash $25.00 take-private of Avanos by American Industrial Partners is now a near-closed pin: all regulatory approvals obtained 2026-07-02, leaving only the 2026-07-22 shareholder vote before an expected close by 2026-07-27. The spread…
AZTA
Azenta, Inc.
Value-unlock special situation, not momentum: ~$10.90/share net cash, Politan Capital (~10%) on the board, and a portfolio review under a new multiomics chief. The ~+60% bounce off the $15.93 low has run ahead of still-contracting organic…
BAK
Braskem S.A.
Distress jumped from the Idesa JV to the parent: ~2026-06-29 Braskem S.A. won a 60-day creditor standstill, Fitch cut to C and S&P to D (default), and JPMorgan capitulated to Neutral (2026-06-30) as creditors rejected management's plan and…
BH
Biglari Holdings Inc.
Holdco discount has flipped to a slight premium to ~$401/Class B book as a Cracker Barrel mark-to-market windfall (CBRL +73% YTD) and the Steak 'n Shake Bitcoin/tallow revival re-rate NAV. But the tape is post-parabolic off the $476.92 Jan…
BTGO
BitGo Holdings, Inc.
Broken IPO (~$5.13 vs $18 Jan listing) that just printed a fresh all-time low at $4.67 as the 2026-06-17 buyback bounce faded rolling into a 2026-07-21 lockup unlock (~10 days out), a new 15% layoff, and a fresh IPO-period securities class…
CADL
Candel Therapeutics, Inc.
CAN-2409 narrative re-armed on the 2026-06-30 AURORA Phase 3 launch in post-ICI NSCLC a second pivotal program in a far larger indication plus an ex-AstraZeneca lung CCO hire; the stock cleared the old $9.27 high to an $11.36 peak, then…
CCRN
Cross Country Healthcare, Inc.
Deal-pinned cash merger-arb, not a momentum trade. Knox Lane taking CCRN private at $13.25 cash; HSR cleared 2026-06-22 for both the merger and the locums sale, leaving only the 2026-07-16 shareholder vote. ~0.3% capped upside vs ~25%…
CCXI
Churchill Capital Corp XI
Humanoid-robotics de-SPAC: Churchill Capital XI is merging with Agility Robotics (~$2.5B, Nvidia/Amazon-backed, re-lists as AGLT). Theme is accelerating, but the tape is a vertical RSI-98 blow-off on filing headlines the premium above the…
CNTA
Centessa Pharmaceuticals plc
Resolved special situation: Lilly closed its $38.00 cash plus up-to-$9.00 non-transferable CVR scheme on 2026-06-24 after the 2026-06-22 High Court sanction; last Nasdaq ADS trade was 2026-06-23 and shares have delisted and are…
CODI
Compass Diversified
Post-fraud recovery (+~115% off the $4.58 low) has stalled: a 2026-07-01 +9% pop to $11.57 faded back under the 50-day (~$11.14) to ~$10.08 by 2026-07-08 on volume 53% below average. Only live optionality is the delayed Management Services…
CPIX
Cumberland Pharmaceuticals Inc.
Deal-arb thesis is now spent: the $100M Apotex asset sale closed 2026-07-01 after a 99.84% shareholder vote on 2026-06-24, so the dated binary that drove the ~3.2x off $1.85 to a $7.36 high is consumed. What remains is a cash-rich clinical…
CRTO
Criteo S.A.
Deal-or-no-deal special situation: the 2026-07-06 Vista/Quinti take-private bid >$50 against a ~$23 tape implies the market prices only low-teens completion odds, earned by Criteo's serial failed-sale history. The momentum pop already…
CXT
Crane NXT, Co.
Currency/payments spinoff re-rating into an authentication & traceability roll-up (De La Rue + Antares Vision); SAT sales +51% YoY, FY sales guide hiked to 15–17%. A June 27 Russell large-cap ejection forced a washout to ~$47.48; price is…
DNUT
Krispy Kreme, Inc.
McDonald's growth engine is permanently dead (deal terminated July 2 2025 on $28.9M of unsustainable cost); what's left is an asset-light refranchising turnaround with Q1 FY2026 Adjusted EBITDA +38% YoY on -2.2% revenue. Real margin…
DXYZ
Destiny Tech100 Inc.
Closed-end SpaceX proxy whose entire bull case the pre-IPO scarcity premium is now dead: SpaceX trades publicly (SPCX, $135 IPO 2026-06-12, ran to $225, back near ~$145 lows by 2026-07-10). DXYZ's premium has collapsed from ~151% (May)…
ENTG
Entegris, Inc.
WFE-upcycle consumables re-rate now MATURING: after a +30% two-week run to ~$181 on the JSR/Inpria EUV cross-license and CNBC coverage, July sell-side is splitting Mizuho to $200 (07-01) vs Deutsche Bank Hold $155 (07-06), BMO $167 with…
ESPR
Esperion Therapeutics, Inc.
ARCHIMED take-private cleared its last binary: the 2026-07-08 vote adopted the deal (135.3M for vs 22.8M against), and with HSR and German antitrust already done only the mechanical Q3 close and Nasdaq delisting remain. Stock is pinned at…
EVER
EverQuote, Inc.
Matured auto/home insurance lead-gen cyclical that re-rated on the tape: a +6.91% breakout on 2026-06-26 (~4x average volume) reclaimed the declined ~$20.30 200-DMA, confirmed by a live estimate-revision cycle (Zacks consensus EPS +21% in…
FTRE
Fortrea Holdings Inc.
CRO margin-turnaround already re-rated FTRE ~4x off its 2025 low; the Q1 beat that drove it is spent and price sits ~9% under the $18.67 52-week high, above most analyst targets. Fresh positive drift (Zacks Strong-Buy 7/7 on +31% estimate…
FWRD
Forward Air Corporation
Busted-merger workout losing its bid: the +48% June bounce to $14.87 (on a speculative Amazon-bolt-on thesis) has faded ~13% to ~$13, whole-company sale is now reported "unlikely," and the 2026-07-10 chairman exit forfeited…
GBTG
Global Business Travel Group, Inc.
Signed $9.50/share cash take-private by Long Lake (~$6.3B; General Catalyst + Alpha Wave backed); 69% of shares locked via voting agreements, close guided 2H 2026. Stock pinned ~$9.36 pure merger-arb with ~1.5% capped upside vs ~37%…
GCMG
GCM Grosvenor Inc.
Alternatives-manager re-rating: infrastructure and private-credit fundraising (AI-power capex driven) plus a $9.8B contracted-not-yet-fee-paying AUM backlog point to fee-earnings acceleration but reported Q1 FRE was flat YoY and shares sit…
GCO
Genesco Inc.
The operating turnaround is real but priced, and its one asymmetric leg the activist proxy fight lost its teeth: ISS (2026-07-07) backed all nine board directors and urged holders to withhold from the two Radoff/Jumana nominees, so the…
GTX
Garrett Motion Inc.
Turbo cash-cow re-rated (~8–9x → ~18x) on a datacenter/industrial oil-free cooling narrative; the parabolic Feb→June leg (~$20→$36) is spent, shares faded ~11% to the 50-day near $32.30, and the ~late-July Q2 print is the first chance to…
HELE
Helen of Troy Limited
Q1 FY2027 (2026-07-08) beat the guided-breakeven bar Adj EPS $0.17 vs $(0.01) est, sales $402M vs $375M, sales guide nudged up and analysts lifted PTs to $25–28. The turnaround binary resolved favorably, but the stock now sits at fair…
HNI
HNI Corporation
Transformational Steelcase merger (closed 2025-12-10) made HNI the #1 North American office-furniture maker at ~$5.8B revenue, but the tape is broken near $40 versus ~$70 analyst targets a show-me integration grind, not an accelerating…
HPP
Hudson Pacific Properties, Inc.
West Coast office/studio REIT that nearly tripled off the April $5.51 low; operating recovery is real but the move has matured into a split $12–$16 analyst cluster with B of A now at Underperform. The trade is now a binary ~$566M CMBS…
IDYA
IDEAYA Biosciences, Inc.
Precision-oncology name digesting a $300M raise at $27.00 (priced 2026-06-09); analysts cut targets 2026-07-07 (RBC $48, Truist $63) while staying bullish. Darovasertib uveal-melanoma registrational path is the embedded option, but the…
IHRT
iHeartMedia, Inc.
M&A special-sit stays the dormant leg SiriusXM talks stalled over the divestiture/antitrust impasse and unrevived but the $6.56 April spike stabilized near $4.05 instead of bleeding out, and a fundamental H2 story (2026 midterm…
IMRX
Immuneering Corporation
Post-ASCO sell-the-news biotech: atebimetinib's 17.3-month first-line pancreatic OS is real but single-arm, and the Phase 3 OS binary is ~2 years out (mid-2028). Near-term is a coverage and base-building story with no dated OS catalyst…
INHD
Inno Holdings Inc.
Halted micro-cap: the $39.49 last print (June 8, 2026) was a 3,660% blow-off from $1.05 on a $3M AI 'used-phone sales agent' deal, after which Nasdaq froze it under T12 and the board opened a probe into its own trading. No live tradeable…
IPAR
Interparfums, Inc.
Up ~39% YTD on a rotation-into-quality-defensives bid, but FY2026 guidance is EPS $4.85 a ~5% decline as Interparfums invests through a trough year toward a 2027 license rollout. The move is multiple expansion, not earnings; sell-side PTs…
JACK
Jack In The Box Inc.
Beaten-down QSR micro-cap (~$328M cap) near-doubled off its $8.91 low on the JACK-on-Track deleveraging story the $500M notes refi (closed 2026-06-23) cleared near-term maturities and squeezed a heavily-shorted float, fueled by a +367%…
KALV
KalVista Pharmaceuticals, Inc.
The Chiesi takeout is done: the tender expired with ~77.8% of shares in (43,152,532 sh), the second-step merger went effective 2026-06-11 at $27.00/share cash, and KALV ceased trading on Nasdaq before the open the same day. No US-listed…
KODK
Eastman Kodak Company
Pension-reversion fat pitch already fired (completed Dec 2 2025; net-cash, $337M FY25 cash) and the re-rate peaked at $14.87 on May 4 before a ~34% correction into a $9.4–9.8 range. What's left is an early, unsigned battery-electrode and…
KURA
Kura Oncology, Inc.
Ziftomenib/Komzifti approval (2025-11-13) already de-risked the story; the Street's $24-28 targets underwrite a frontline-AML expansion gated to a 2028 Phase 3. Stock consolidates near its $12.49 52-week high on a slow launch ($5.8M Q1)…
LAR
Lithium Argentina AG
Lithium-recovery momentum has rolled over and the mean-reversion is now largely complete: LAR retraced from a ~$12.05 May high to a $7.79 Jun-26 close, losing the $8 breakout shelf as China carbonate fell from the CNY 200,500 May-13…
LIFE
Ethos Technologies Inc.
Contested insurtech IPO just staged a ~28% three-session reclaim of the $19 IPO price and the ~$19.40 pivot (closed $19.58, 2026-06-26) as analyst PTs cluster up to $26–30. Base-reclaim is improving but unconfirmed an unresolved…
LILA
Liberty Latin America Ltd.
Malone-led insider cluster 30+ Form 4 buys in 30 days across the chairman, CEO Balan Nair and multiple directors is accumulating a beaten-down Caribbean telecom into a fresh $500M 9% preferred distribution. The signal is real, but price…
LILAK
Liberty Latin America Ltd.
Deep-value Malone-complex LatAm telecom that ripped ~55% off 52-week lows on a $500M Series A preferred special dividend (declared May 21, distributed June 16) plus a heavy June insider cluster Malone, CEO Nair and three directors. No…
LOVE
The Lovesac Company
Q1 FY27 (2026-06-11) was a modest beat sales $138.2M in-range, net loss $11.1M well inside the −$0.95/−$1.22 guide yet shares stayed pinned near $16 in the lower third of the 52-wk range.
MGM
MGM RESORTS INTERNATIONAL
The narrative rotated from June's $48.30 Diller/People Inc. Take-private to an accelerating BetMGM sports-betting thread (MLB deals renewed 2026-06-23; Pompliano handle-vs-Amazon piece 2026-06-29). But the unresolved cash bid still pins…
NKTR
Nektar Therapeutics
Feb-2026 REZOLVE-AD maintenance pop to $109 has fully round-tripped; NKTR has stabilized near $62 — but the next true binary (ZENITH-AD Phase 3 AD readout) is mid-2028, so there is no accelerating leg to buy. The mechanism is de-risked yet…
OGN
Organon & Co.
Takeover binary resolved; OGN trades as deal-pinned merger-arb on Sun Pharma's $14.00 all-cash bid. The HSR waiting period lapsed 2026-06-22 with no second request disclosed, and the 2026-07-23 stockholder vote is the last discretionary…
OLPX
Olaplex Holdings, Inc.
Henkel all-cash takeout at $2.06 is de-risking fast: Germany's Bundeskartellamt cleared 2026-06-16 and Australia's ACCC cleared shortly after; only US (HSR) and UK (CMA) gates remain for an H2-2026 close. Stock pegged ~$2.05, ~0.5% gross…
PBI
Pitney Bowes Inc.
Activist turnaround (Hestia's Kurt Wolf as CEO) is a finished financial-engineering re-rate ~2x off the $8.95 low, now pinned at the 52-wk-high $17.62 zone on a buyback/cost-cut EPS story while revenue still shrinks ~3% YoY. MATURING…
PGNY
Progyny, Inc.
Fertility-benefits turnaround re-rate is MATURING but still bid stock grinding $25→$27 toward the $28.75 52-wk high while Street targets keep rising (Truist $33 on 6/22, avg ~$30). No binary until the 2026-07-30 Q2 print; constructive but…
PII
Polaris Inc.
Powersports margin-recovery leg ($52→$75.24) overshot the PT cluster, rolled to $66 on 2026-06-05, then stabilized now $68.68, parked on the $68.30 consensus target. Special-sit catalyst (Indian/Carolwood sale, closed 2026-02-02) is spent;…
PNRG
PrimeEnergy Resources Corporation
The geopolitical oil bid that drove June's +11.5% bounce has broken: WTI cratered to $68.86 (2026-06-26), under $70 for the first time since February as the Iran premium deflates. Offsetting it Waha gas flipped positive and a fresh…
QRVO
Qorvo, Inc.
Not a standalone story since the 2025-10-27 Skyworks bid ($32.50 cash + 0.960 SWKS/sh). Trades as a leveraged SWKS proxy with a ~33% cash floor; upside capped at deal value, downside binary on China's SAMR review the last of three…
RAMP
LiveRamp Holdings, Inc.
Pending all-cash takeout, not a momentum vehicle: Publicis $38.50/share cash deal (signed 2026-05-16) pins RAMP near the cap with a ~2.9% arb spread to a year-end-2026 close. Upside is hard-capped at the contract price; a deal-break gaps…
RLYB
Rallybio Corporation
Special-situations reverse merger, not a momentum trade: 2026-06-01 Avenzo deal + $215M PIPE; combined co trades AVZO, closes Q4 2026. Stock holds near 52-wk highs (~$15.71, 2026-06-25) as the market credits stub+CVR optionality, but…
RMAX
Re/Max Holdings, Inc.
Merger-arb shell, not a momentum name. REAX's near-all-stock takeover (5.150 REAX/sh, cash capped $60–80M) is worth ~$9.63 in stock at REAX $1.87; RMAX trades ~$9.5, at/through parity. REAX's bounce off $1.68 closed the spread no edge…
RPAY
Repay Holdings Corporation
Two-activist takeout fight resolved against longs: the board rejected Forager's $4.80 bid (5/4), closed the debt-funded KUBRA deal (6/1), and survived the 6/10 meeting where directors held their seats despite a historic ~37% withhold vote.…
STAA
STAAR Surgical Company
Post-Alcon-break special situation where the June 18 standstill expiry + annual meeting passed with no renewed sale process Broadwood slate re-elected, equity plan boosted, nothing on a sale. The near-term M&A binary deflated. Residual…
SYNA
Synaptics Incorporated
Edge-AI re-rating got cashed out: ON Semi's 2026-06-25 all-stock bid (1.35 ON shares/SYNA, ~$160 implied, ~$7B) caps SYNA as a merger-arb spread, not a momentum name. It now tracks ON's price and antitrust odds into a mid-2027 close; the…
TBRG
TruBridge, Inc.
Signed all-cash merger now de-risked: IKS Health buying TruBridge at $26.25 cash, HSR waiting period expired 2026-06-22, leaving only the 2026-07-07 shareholder vote. Stock pinned near the cash cap = sub-1% spread to a Q3 close. The…
TORO
Toro Corp.
Panagiotidis shipping shell (NOT lawnmower TTC) already ran 1.93→8.50 (~4.4x) on a sub-NAV/special-dividend story now spent; the $0.90 June div paid mostly as 5.7M NEW shares serial dilution dressed as capital return. At ~$4.84 the cap…
UI
Ubiquiti Inc.
The May 8 print broke the parabola: a 47.0% gross-margin beat and +18.7% revenue couldn't save a $3.88 EPS that missed the run-up to ~$4.42, and cash halved to $176M. Near $567 and ~48% off the $1,100 top with no catalyst until the ~Aug 21…
UNIT
Uniti Group Inc.
Post-Windstream fiber REIT re-rating on AI-datacenter demand: the hyperscaler dark-fiber funnel is now a disclosed ~$1.5B contract value (~40% of pipeline vs <15% a year ago), driving a ~42% three-week run to $11.07 past the $10.25…
VECO
Veeco Instruments Inc.
Merger-arb tracking stock for Axcelis: fixed 0.3575 ACLS/VECO, both votes passed 2026-02-06, only China SAMR remains (outside date 2026-09-30). Upside is ratio-capped and the live binary is the SAMR sign-off which has run slow and may move…
WSC
WillScot Holdings Corporation
H2-2026 leasing inflection plus a data-center vertical guided +50% revenue, under an activist/PE takeover floor but a 2026-06-27 Russell growth-index removal forced passive selling, consensus PTs ($24.25) sit below the ~$27 tape, and the…
XRX
Xerox Holdings Corporation
Activist-anchored distressed-deleveraging special situation that fully round-tripped the June pop: $3.49 (2026-06-04) back to ~$2.80 (2026-07-02, -9.7% on the day), now at/below the $2.50 average target after Citi cut $3.50→$2.50.…
XTLB
XTL Biopharmaceuticals Ltd.
Delisting binary resolved to the survive side: EGM passed 2026-06-29, Psyga psilocybin reverse-merger closed 2026-06-30, delinquent 20-F filed, Nasdaq listing held. ADS popped ~+90% intraday to ~$2.70 (~$6.4M cap). Now an illiquid…